期刊文献+

前哨淋巴结活检对乳腺癌外科导航的临床分析 被引量:7

A clinical analysis of the surgery value of sentinel node biopsy in beast cancer
下载PDF
导出
摘要 目的 探讨前哨淋巴结活检 (SLNB)对乳腺癌手术导航的临床价值及可靠性。方法 用染料法(1%亚甲蓝 )对 30例乳腺癌病人进行腋窝前哨淋巴结 (SLN)染色切除。术中冰冻切片 ,术后石蜡切片 ,并常规行腋窝淋巴结清除术 (ALND)。结果 SLN染色成功率 96 7% (2 9/ 30 ) ,失败 1例。SLN阳性 10例 ,后站淋巴结有癌转移 6例 (6 0 % ) ,无癌转移 4例 (4 0 % )。SLN阴性 19例 ,其中假阴性 1例 ,后站淋巴结均无癌转移。SLNB评价 :检出率 96 7%、准确率 93 3%、敏感度 90 9%、假阴性率 9 1%、假阳性率 0。结论 只要提高技术水平 ,SLN染料着色和检出率都相对较高 ,对外科术式选择有实际指导意义。相信SLNB取代传统的ALND已为时不远。 Objective To analyze the clinicla value and reliability of sentinel lymph node biopsy(SLNB)in breast cancer surgery.Methods Thirty breast cancer patients had been operated by sentinel node biopsy and stained with 1% methylene blue.There had Gryo-section during operation and paraffin wax-section after operation.Operation concluded excision of axillary lymph node.Results The successful rate of sentinel node stain was 96.7%(29/30),one patient's sentinel node hadn't stain with this method,10 patients had positive sentinel node,in these patients,6 had another axillary node metastasis and 4 hadn't another axillary node metastasis.Nineteen patients had negative sentinel node,but one patient had false-negative result.The evaluation of SLNB:The usccessful rate was 96.7%,accuracy was 93.3%,sensitivity was 90.9%,false-negative rate was 9.1% and false-positive rate was 0.Conclusion At present,many factors and problems need deep research in SLNB,so the SLNB of breast cancer is in clinical investigation stage.But we think not long after the old ALND is going to substitute with SLNB.
出处 《现代肿瘤医学》 CAS 2004年第3期203-204,共2页 Journal of Modern Oncology
关键词 乳腺癌 外科学 前哨淋巴结 染色法 淋巴转移 breast cancer surgery sentinel lymph node stain methods lymph node metastasis
  • 相关文献

参考文献10

  • 1尉承泽.乳腺癌哨兵淋巴结检测[J].国外医学(肿瘤学分册),2003,30(2):104-106. 被引量:19
  • 2蔡长友,黄丽萍,赵卫东,杨海明.乳腺癌前哨淋巴结定位活检的意义(附68例分析)[J].陕西肿瘤医学,2001,9(3):209-209. 被引量:2
  • 3方志沂,刘君.现代乳腺癌外科发展趋势[J].国外医学(肿瘤学分册),2003,30(1):34-37. 被引量:40
  • 4[4]Mcmasters KM,Giuliano AE,Ross MI,et al.Sentinel lymph node biopsy for breast cancer not yet the standard of care[J].N Eng1 J Med,1998,399(4):990.
  • 5[5]Veronesi U,Paganelli G,Galimberti V,et al.Sentinel node biopsyto avoid axillary dissection in breast cancer with clinically negative lymph nodes[J].Lancet,1997,349(9069):1864~1867.
  • 6[6]Giuliano AE,Jones RC,Brennan M,et al.Sentinel lymphadenectomy in breast caner[J].J Clin Oncol,1997,12(6):2345.
  • 7[7]Crossin JA,Johnson AC Stewart PB,et al.Gamma-probe-guided resection of the sentinel lymph node in breast cancer[J].Am Surg,1998,64(7):666~669.
  • 8[8]Uren RF,Howman Gile R,Renwick SB,et al.Lymphatic mapping of the breastlocatint the sentinel lymph nodes[J].Would Surg,2001,25(6):789~793.
  • 9[9]Turner RR,Ollila DW,Stern S,et al.Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging[J].Am J Surg Pathol,1999,23(3):263~267.
  • 10[10]Motomura K, komoike Y,Inaji H,et al.Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer[J].Br J Surg,2002,89(8):1032~1034.

二级参考文献14

  • 1O'Hea BJ, Hill AD, El Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center [J]. J Am Coll Surg, 1998, 186(4): 423-427.
  • 2Cox CE, Dupont E, Whitehead GF, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer [J]. Breast J, 2002, 8(2) : 88-91.
  • 3Creager AJ, Geisinger KR. Intraoperative evaluation of sentinel lymph nodes for breast carcinoma: current methodologies [J]. Adv Anat Pathol, 2002,9(4): 233-243.
  • 4Motomura K, Komoike Y, Inaji H, et al. Multiple sectioning and immunohistochemicsl staining of sentinel nodes in patients with breast cancer [J]. Br J Surg, 2002, 89(8): 1032-1034.
  • 5Schrenk P, Rehberger W, Shamiyeh A, et al. Sentinel node biopsy for breast cancer : does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node [J]. J Surg Oncol,2002, 80(3): 130-136.
  • 6Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer [J]. Breast J, 2002, 8(2) : 97-100.
  • 7Schrenk P, Hatzl Griesenhofer M, Shamiyeh A, et al. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection [J]. J Surg Oncol, 2001, 77(3): 165-170.
  • 8Meijer S, Torrenga H, van der Sijp JR. Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases [J]. Ned Tijdschr Geneeskd, 2002, 146(20): 942-946.
  • 9Chung MA, Steinhoff MM, Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy [J]. Am J Surg, 2002, 184(4): 310-314.
  • 10Hansen NM, Grube BJ, Giuliano AE. The time has come to charge the algorithm for the surgical management of early breast cancer[J]. Arch Surg, 2002, 137(10): 1131-1135.

共引文献57

同被引文献40

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部